ERNA · Ernexa Therapeutics Inc. · Earnings Call Transcripts & Audio
$4.17
+0.15 (+3.61%)
At close · Sep 11
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“As of June 30, 2026, the Company had approximately $5.0 million in cash, which is less than that needed to effect its current operating plan and forecasted cash requirements for the next twelve months. However, management expects that its ability to access capital under its ATM will cover shortfalls in its cash resources over the next twelve months from the issuance date of these financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$6.80M
Shares
1.63M
Ernexa Therapeutics Inc. Earnings Call Transcripts
Quarterly earnings calls for Ernexa Therapeutics Inc. (ERNA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY20 · Q2
2020-08-07
Ernexa Therapeutics Inc. (ERNA) Q2 2020 Earnings Call
Revenue
$754,000
▼ 85.6% YoY Diluted EPS
$-900.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-19
Ernexa Therapeutics Inc. (ERNA) Q1 2020 Earnings Call
Revenue
$2.39M
▼ 50.5% YoY Diluted EPS
$-450.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-17
Ernexa Therapeutics Inc. (ERNA) Q4 2019 Earnings Call
Revenue
$5.17M*
▼ 12.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–3 of 3 earnings calls